Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Short and Distort

The SEC on Wednesday charged Gregory Lemelson and Lemelson Capital Management with fraudulently making $1.3 million by driving down the price of nonparty Ligand Pharmaceuticals in a “short-and-distort” scheme.

BOSTON — The SEC on Wednesday charged Gregory Lemelson and Lemelson Capital Management with fraudulently making $1.3 million by driving down the price of nonparty Ligand Pharmaceuticals in a “short-and-distort” scheme.

Categories / Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...